Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone and Pegylated Liposomal Doxorubicin in Advanced Ovarian or Peritoneal Cancer
NCT00182767Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2006
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in ovarian epithelial cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), breast cancer, sponsored by National Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
ixabepilone
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)breast cancer
Beyond the preview
Go deeper on NCT00182767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182767.